Earl W. Phelan, Radioisotopes in Medicine
“ There 37 may be a small increase in the number of cases of leukemia among those treated with 32P compared with the general population. The controversy arises over whether the 32P treatment caused the leukemia, or whether it merely prolonged the lives of the patients until leukemia appeared as it would have in these persons even without treatment. This is probably quibbling, and many doctors believe that the slight unproven risk is worth taking to produce the admitted lengthy freedom from symptoms. ”
